Historical Stock Price
ETFs Holding ABT »    ABT Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
01/12/2017 $40.79 $40.79 $40.31 $40.72 8.63M
01/13/2017 $40.75 $41.36 $40.69 $40.93 9.53M
01/17/2017 $40.67 $41.04 $40.53 $40.90 8.27M
01/18/2017 $41.05 $41.10 $40.51 $40.76 7.20M
01/19/2017 $40.64 $40.73 $40.24 $40.40 7.16M
Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a line of health care products. Co.'s reportable segments are: Established Pharmaceutical Products, which sells a line of generic pharmaceutical products; Diagnostic Products, which sells diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites; Nutritional Products, which sells a line of adult and pediatric nutritional products; and Vascular Products, which includes a line of coronary, endovascular, structural heart, vessel closure and other medical device products. Non-reportable segments include the Diabetes Care and Medical Optics segments.
ABT historical stock prices picture
Abbott Laboratories (ABT) has the following price history information. Looking back at ABT historical stock prices for the last five trading days, on January 12, 2017, ABT opened at $40.79, traded as high as $40.79 and as low as $40.31, and closed at $40.72. Trading volume was a total of 8.63M shares. On January 13, 2017, ABT opened at $40.75, traded as high as $41.36 and as low as $40.69, and closed at $40.93. Trading volume was a total of 9.53M shares. On January 17, 2017, ABT opened at $40.67, traded as high as $41.04 and as low as $40.53, and closed at $40.90. Trading volume was a total of 8.27M shares. On January 18, 2017, ABT opened at $41.05, traded as high as $41.10 and as low as $40.51, and closed at $40.76. Trading volume was a total of 7.20M shares. On January 19, 2017, ABT opened at $40.64, traded as high as $40.73 and as low as $40.24, and closed at $40.40. Trading volume was a total of 7.16M shares.

ABT Historical Stock Prices By Date:

ABT historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Abbott Laboratories shares, starting with a $10,000 purchase of ABT, and working forward through the historical stock price information to today.

Growth of $10,000.00
With Dividends Reinvested

Start date: 01/22/2007
End date: 01/19/2017
Start price/share: $25.58
End price/share: $40.40
Starting shares: 390.93
Ending shares: 508.60
Dividends reinvested/share: $8.13
Total return: 105.47%
Average Annual Total Return: 7.47%
Starting investment: $10,000.00
Ending investment: $20,552.87
Years: 10.00
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/22/2007
End date: 01/19/2017
Start price/share: $25.58
End price/share: $40.40
Dividends collected/share: $8.13
Total return: 89.72%
Average Annual Total Return: 6.61%
Starting investment: $10,000.00
Ending investment: $18,966.16
Years: 10.00
Date Close
01/12/2017$40.72
01/13/2017$40.93
01/17/2017$40.90
01/18/2017$40.76
01/19/2017$40.40
ABT is categorized under the Healthcare sector; below are some other companies in the same sector:

ABUS Historical Stock Prices
ACAD Historical Stock Prices
ACET Historical Stock Prices
ACHC Historical Stock Prices
ACHN Historical Stock Prices
ACIU Historical Stock Prices
ACOR Historical Stock Prices
ACRS Historical Stock Prices
ACRX Historical Stock Prices
ACST Historical Stock Prices

ABT Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.